Suppr超能文献

针对重度肥胖的强化极低热量饮食计划的益处与风险。

Benefits and risks of an intensive very-low-calorie diet program for severe obesity.

作者信息

Anderson J W, Hamilton C C, Brinkman-Kaplan V

机构信息

Metabolic Research Group, University of Kentucky College of Medicine, Lexington.

出版信息

Am J Gastroenterol. 1992 Jan;87(1):6-15.

PMID:1728126
Abstract

Comprehensive very-low-calorie diet (VLCD) programs are the preferred treatment for selected obese individuals. They combine energy intakes of 400-800 kcal/day with medical monitoring and intensive lifestyle education. Typical VLCD patients have median body mass indexes of 36 kg/m2 and have median ages of 40 years. About 70% are female. Commonly associated medical problems include hypertension in 50%, hyperlipidemia in 41%, and diabetes mellitus or glucose intolerance in 14%. Typical weight loss with VLCD is around 21 kg in 16 wk. Reductions of 8-13% in blood pressure, 5-15% in serum total cholesterol, 5-20% in low-density lipoprotein-cholesterol, 15-50% in triglycerides, and decreases in blood glucose and glycohemoglobin in diabetic individuals accompany weight loss. VLCD-associated side effects can be managed medically without discontinuing treatment. Lifestyle education promotes long-term weight maintenance of approximately 56% 2 yr after VLCD treatment. Weight losses using comprehensive VLCDs allow moderately to morbidly obese persons to achieve greater benefits than other nonsurgical treatments and should be considered before opting for surgical treatment.

摘要

综合性极低热量饮食(VLCD)方案是特定肥胖个体的首选治疗方法。它们将每日400 - 800千卡的能量摄入与医学监测和强化生活方式教育相结合。典型的VLCD患者体重指数中位数为36 kg/m²,年龄中位数为40岁。约70%为女性。常见的相关医疗问题包括50%的高血压、41%的高脂血症以及14%的糖尿病或葡萄糖耐量异常。VLCD治疗的典型体重减轻在16周内约为21千克。体重减轻伴随着血压降低8 - 13%、血清总胆固醇降低5 - 15%、低密度脂蛋白胆固醇降低5 - 20%、甘油三酯降低15 - 50%,以及糖尿病患者血糖和糖化血红蛋白降低。VLCD相关的副作用可以通过医学手段处理而无需中断治疗。生活方式教育可促进VLCD治疗后2年约56%的患者长期维持体重。使用综合性VLCD进行体重减轻使中度至重度肥胖者比其他非手术治疗获得更大益处,在选择手术治疗之前应予以考虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验